TrialDevelopmental medicine and child neurology2025

Glycopyrronium 320 μg/mL in children and adolescents with severe sialorrhoea and neurodisabilities: An open-label study extension of the SALIVA trial.

Pierre Fayoux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.